China’s State-Backed Virus Vaccine Has 86% Efficacy, Says UAE
In this article
China’s state-backed coronavirus vaccine protected 86% of people from getting Covid-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry.
The vaccine, developed by Sinopharm unit China National Biotec Group Co., has been granted emergency use authorization in the UAE and administered to frontline medical workers, government health officials and a number of senior ministers, the reports said. The shot already has emergency authorization in China and has been administered to hundreds of thousands of people there in recent months.
CNBG did not immediately respond to requests for comment.
The 86% efficacy rate for one of China’s leading vaccine efforts ranks among the most effective the world has seen, making it a potentially more favorable option to vaccinate large swathes of population in the developing world than frontrunner western efforts.
192,416 in U.S.Most new cases today
+10% Change in MSCI World Index of global stocks since Wuhan lockdown, Jan. 23
-0.7931 Change in U.S. treasury bond yield since Wuhan lockdown, Jan. 23
4% Global GDP Tracker (annualized), Oct.